Dr. Natalia López-Andrés has dedicated her scientific career to biology, graduating from this degree at the University of Navarra. She specialized in cardiovascular sciences by pursuing a PhD at the Division of Cardiovascular Sciences of the University of Navarra, obtaining the PhD in 2006. She holds a postdoctoral position at the Division of Cardiovascular Sciences in the Centre for Applied Medical Research from 2006 to 2008. During these years I worked with a multidisciplinary research team specialized in the study of heart failure. This expertise enabled her to occupy a postdoctoral position at INSERM, in unit U961, from 2008 until January 2013.
This unit focuses its research on the mechanisms of action and the diagnostic and therapeutic aspects applied to the field of cardiovascular stiffness-fibrosis and hypercoagulability. In 2013, I obtained the competitive Miguel Servet contract that allowed me to build a new research group in Navarrabiomed, the Translational cardiovascular research group, at the interface between clinical and basic research. Over the past 12 years my laboratory has investigated the role of Aldosterone/mineralocorticoid receptor and its biotargets in heart valve diseases. The research Programme is part of the “Cardiovascular and Renal Diseases Area” of the Health Research Institute of Navarra (IdiSNA). As part of my research career, I have effectively developed contacts and collaborations in other countries and universities to enhance her knowledge and capabilities. I have participated as a principal investigator in the European FP7 project Fibrotargets, as a work package leader in the COST action ADMIRE and as principal investigator in national and regional projects.
